The Effectiveness of Transcranial Magnetic Stimulation and Mirror Therapy in Hemispatial Neglect
NCT ID: NCT07228871
Last Updated: 2025-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
22 participants
INTERVENTIONAL
2025-10-09
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Efficacy of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Unilateral Neglect in Patients With Subacute-Chronic Phase After Ischemic Stroke
NCT06223451
The Effect Of Transcranial Magnetic Stimulation In Patients With Stroke
NCT04562415
Effects of Intermittent Theta Burst Stimulation in Addition to Constraint-Induced Movement Therapy in Stroke Patients
NCT05308667
The Effects of Cerebellar Intermittent Theta Burst Stimulation on Gait, Balance, and Disease Anxiety In Stroke Patients
NCT06696547
Comparison of the Effects of Mirror Therapy,rTMS and Robotic-assisted Hand Therapy in Stroke Patients
NCT06750692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active cTBS + mirror therapy group
Mirror Therapy
Mirror therapy will be administered 5 days a week for 2 weeks.
cTBS
Patients received cTBS applied to the P3 region according to the 10/20 electroencephalogram system for 5 days a week, totalling 10 sessions over 2 weeks.
Cognitive rehabilitation
Methods that facilitate adaptation in daily life activities will be taught.
Sham cTBS + mirror therapy
Mirror Therapy
Mirror therapy will be administered 5 days a week for 2 weeks.
Cognitive rehabilitation
Methods that facilitate adaptation in daily life activities will be taught.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mirror Therapy
Mirror therapy will be administered 5 days a week for 2 weeks.
cTBS
Patients received cTBS applied to the P3 region according to the 10/20 electroencephalogram system for 5 days a week, totalling 10 sessions over 2 weeks.
Cognitive rehabilitation
Methods that facilitate adaptation in daily life activities will be taught.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Right hemisphere lesion
3. Patients with a duration of more than 7 days but less than 1 year from the date of the event
4. Aged between 18 and 75 years
5. Patients with a Mini Mental Test Score ≥ 24
Exclusion Criteria
2. Presence of vision or hearing problems
3. Use of medication affecting cognitive function
4. History of epilepsy
5. Pregnancy or breastfeeding
6. History of malignancy
7. Pacemaker
8. Presence of metallic implants in the brain or scalp (including cochlear implant)
9. History of premorbid dementia
10. Presence of psychiatric or additional neurological disease
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Etlik City Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayse Naz Kalem
PM&R Specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AEŞH-EK-2025-164
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.